期刊文献+

垂体腺瘤的治疗进展 被引量:3

下载PDF
导出
摘要 垂体腺瘤(Pitutary abenomas,PA)是一种较为常见的生长缓慢的颅内肿瘤,在颅内肿瘤中仅次于脑胶质瘤和脑膜瘤,约占10%,但尸检发现率为20%~30%,近年有增多趋势。由于影像学及内分泌检查手段和显微外科的进展,PA诊断和治疗水平均有了明显提高,手术并发症和死亡率明显下降。
作者 刘云廷
机构地区 北京军区总医院
出处 《北京军区医药》 2000年第4期252-254,共3页
  • 相关文献

参考文献20

  • 1任祖渊.垂体腺瘤[A].王忠诚主编.神经外科学[J].武汉:湖北科学技术出版社,1998.518-519. 被引量:12
  • 2Black PM, Zervas NT, Candia GL. Incidence and management of complication of transsphenoidal operation for pituitary adenomas. Neurosurgery, 1987 , 20 : 920. 被引量:1
  • 3Laws ER Jr. Surgical management of pituitary adenomas.Curr Probl Cancer, 1984,8: 1. 被引量:1
  • 4关树森,于春江,朱安林,江涛.额下经蝶入路显微手术切除鞍区肿瘤20例报告[J].中华神经外科杂志,1999,15(5):304-306. 被引量:37
  • 5张纪.垂体瘤手术.见段国升,朱诚主编.手术学全集神经外科卷.北京:人民军区出版社,1994.132~138. 被引量:1
  • 6Goel A.Nadkrni T. Surgical management of giant pituitary tumors-a review of 30 casses. Acta Neurochlr Wien, 1996,138 : 1042. 被引量:1
  • 7Black PM, Zervas NT,Candia G. Management of large pituitary adenomas by transsphenoidal surgery. Surg Neurol,1988,29:443. 被引量:1
  • 8Saito K ,Kuwayama A, Yamamoto N ,et al. The transsphenoidal removal of noufunctioning pituitary adenomas with suprasellar extenslons,the open sella method and intentionally staged operation. Neurosurgery, 1995,86 : 668. 被引量:1
  • 9章翔,顾建文,费舟,付洛安,张剑宁,易声禹,张志文,刘卫平,王占祥,贺晓生,杨利孙,宋少军,陈义军.大型垂体腺瘤经蝶显微外科治疗原则与技术[J].中国临床神经外科杂志,1999,4(4):19-20. 被引量:9
  • 10Partington MD,Davis DH,Laws ER,et al. Pituitary adenomas in childhood and adolescence. Results of transsphenoidal surgery. J Neurosurg, 1994,80: 209. 被引量:1

二级参考文献5

  • 1唐懿芳,钟达夫.主成分分析方法对数据进行预处理[J].广西师范大学学报(哲学社会科学版),2002,38(S1):223-225. 被引量:16
  • 2张成 张庆林 等.经额-蝶入路显微行垂体瘤全切除[J].中华神经精神外科杂志,1981,14:197-200. 被引量:1
  • 3张成,中华神经外科杂志,1981年,14卷,197页 被引量:1
  • 4王忠诚,神经外科学.颅内肿瘤,1979年,294页 被引量:1
  • 5Dr. A. Goel,T. Nadkarni. Surgical management of giant pituitary tumours — A review of 30 cases[J] 1996,Acta Neurochirurgica(9):1042~1049 被引量:1

共引文献100

同被引文献17

  • 1Madonna D,Kendler A,Soliman AM.Ectopic growth hormonese creting pituitary adenoma in the sphenoid sinus[J].Ann Otol Rhinol Laryngol,2001,110(1):99-101. 被引量:1
  • 2Ravichandran TP,Bakshi R,Heffner RR,et al.Aggressive giant pituitary adenoma presenting as a nasopharyngeal mass:magnetic resonance imaging and pathologic findings[J].J Neurooneol,2009,41(1):71-75. 被引量:1
  • 3Yaniv E, Roppaport ZH. Endoscopic transeptal transsphenoidal surgery for pituitary tumors [J]. Neurosurgery, 1997;40(5): 944-946. 被引量:1
  • 4Patel YC, Shereen E, Chick CL, et al. Guidelines for the diagnosis and treatment of acromegaly: a Canadian perspective [J]. Clin Invest Med, 2000; 23(3): 172-187. 被引量:1
  • 5Racine MS, Barkan AL. Medical management of growth hormone-secreting pituitary adenomas [J]. Pituitary, 2002; 5(2): 67-76. 被引量:1
  • 6Abs R, Verhelst J, Dominique M, et al. Cabergoline in the treatment of acromegaly: a study in 64 patients [J]. J Clin Endocrinol Metab, 1998; 83(2): 374-378. 被引量:1
  • 7Rocheville M, La nge DC, Kumar U, et al. Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity [J]. Science, 2000; 288(5463): 154-157. 被引量:1
  • 8Marzullo P, Ferone D, Di Somma C, et al. Efficacy of combined treatment with lanreotide and cabergoline in selected therapy resistant acromegalic patients [J]. Pituitary, 1999; 1(2): 115-120. 被引量:1
  • 9Parkinson C, Trainer PJ. Growth hormone receptor antagonists: therapy for acromegaly [J]. Bailliers Best Pract Res Clin Endocrinol Metab, 1999; 13(3): 419-430. 被引量:1
  • 10van der Lely AJ, Hutson KR, Traniner PJ, et al. Long-term treatment of acromegaly with pegvisomant, a growth hormone-receptor antagonist [J]. Lancet, 2001; 358(9295): 1754-1759. 被引量:1

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部